Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Dec 7.
Published in final edited form as: ACS Catal. 2012 Nov 5;2(12):2743–2752. doi: 10.1021/cs300465u

Ligand scaffold optimization of a supramolecular hydrogenation catalyst: Analyzing the influence of key structural subunits on reactivity and selectivity

Nathan C Thacker a, Shin A Moteki a,b, James M Takacs a,*
PMCID: PMC3601680  NIHMSID: NIHMS421355  PMID: 23525350

Abstract

Results are reported for the catalytic asymmetric hydrogenation of two prototypical substrates with a series of more than 150 closely related supramolecular catalysts differing in only their ligand/catalyst scaffold. These modular catalysts are constructed from four subunits and vary widely in their reactivity (no reaction to quantitative yield) and enantioselectivity (racemic to 96% ee). Analysis of the ligand/catalyst scaffold optimization data reveals how each subunit contributes to the effectiveness of the modular supramolecular catalyst. The results suggest that a balance between key elements of rigidity and flexibility is required for the successful catalysts and, moreover, that this balance is required to enable effective fine-tuning via catalyst scaffold optimization.

Keywords: supramolecular catalysis, asymmetric catalysis, asymmetric hydrogenation, self-assembled ligands, self-assembly, rhodium-catalyzed

Introduction

Asymmetric catalysis using chiral metal complexes brings into focus the prominent roles played by chiral ligands. It is the coordinated ligand assembly that is expected to sculpt the topography creating a “chiral catalytic pocket” around the catalytic metal center, which in turn directs the stereochemical course of the catalyzed bond construction. At the same time, the ligand(s) must impart the appropriate characteristics at the metal center to promote reactivity. The successful use of DIPAMP in the early days of rhodium-catalyzed asymmetric hydrogenation defined the strategy of covalently linking chiral ligating groups to organize chirality while exploiting C2-symmetry to define an effective topography via relatively small, rigid metal chelates.1-3 At the time, this approach proved much more successful than the alternative use of two equivalents of a similar monodentate ligand (i.e., PAMP). It has been subsequently shown that appropriately chosen monodentate ligands, presumably ones for which non-bonded interactions between the coordinated ligands restrict their relative orientation and thereby organize the chiral pocket for catalysis, can also give very effective catalyst systems.4-8 These two, now standard, approaches to organizing chirality at the site of catalysis (i.e., Mcat) are illustrated schematically by structures 1 and 2 (Figure 1). Their success raises the question, what other approaches can be exploited to organize the chiral ligating groups and create the topography needed for efficient new catalyst systems?9

Fig. 1.

Fig. 1

Organizing chirality (i.e. L*) via a short covalent tether (1), non-bonded interactions (2) and metal complexation (3, MS represents a metal complex whose role is principally structural).

Hydrogen bonding and metal complexation are common structural motifs used in nature to direct the three dimensional assembly of a protein framework so as to position the active site functionalities and create the chiral pocket for biocatalysts.10 We and others are exploring the use of these strategies to organize chirality and define the topography for supramolecular chemocatalysts11-18 building on the studies of supramolecular chemistry19-26, especially in the context of ligands and organometallic catalysts constructed via self-assembly whether by metal complexation,27-34 hydrogen bonding35-46 or non-bonded interactions. 47 The concept is illustrated schematically by the bimetallic catalyst (i.e., structure 3) shown in Figure 1.

Among the fundamental questions underpinning investigations into supramolecular catalyst systems are whether such strategies can be used to give effective catalysts, for example asymmetric catalysts, and whether the strategies employed to prepare such catalysts offer advantages over the traditional approaches. One potential advantage offered by self-assembled systems is that combinatorial methods can be exploited to facilitate ligand/catalyst synthesis. Another is the potential to fine tune catalyst performance in ways not as readily available with the traditional approaches. However, many challenges remain. Among these, one finds that while significant progress has been made towards understanding how to optimize catalyst performance using the classical small-molecule catalyst motifs,48-49 other than the design of efficient screening protocols,50-51 much less is known about how to optimize the performance of supramolecular catalysts. The present study of ligand/catalyst scaffold optimization analyzes data obtained from the rhodium-catalyzed asymmetric hydrogenations of two prototypical enamide substrates to illustrate how each subunit of the modular supramolecular catalyst contributes to its effectiveness.

Results and discussion

The hetereobimetallic complex 4 (Figure 2) defines a series of self-assembled supramolecular catalysts. Catalysts based on this design have previously been used for efficient asymmetric allylic amination52 and catalytic asymmetric hydroboration.53,54 These complexes incorporate one metal (i.e., Zn(II)), whose key role is presumably only structural, and a second metal, designated Mcat, whose key role is to catalyze the desired reaction. Structure 4 is modular in its design and comprised of four subunits: an active site (subunit I); ligating groups (subunit II); scaffold-building tethers (subunit III); and recognition elements (subunit IV). Chiral bisoxazolines (box) serve as the recognition elements to direct self-assembly via chiral discrimination. That is, box subunits of complementary chirality combine with Zn(II) to form the thermodynamically favored heteroleptic complex with high selectivity (Figure 3).55-56 Each box moiety bears a variable scaffold-building tether (ST and RT) consisting of an aryl or biaryl ring whose structure is further varied by the ortho-, meta- or para-substitution pattern of those rings. Each tether is terminated by an aryloxy (ArO-, tethers A–H) or a hydroxymethyl group (ArCH2O-, tethers I–P).

Fig. 2.

Fig. 2

General structure representing a series of heterobimetallic supramolecular catalysts 4 derived from SALs Zn(STRT) in which combinations of tethers ST and RT (ST, RT = A-P) generate a collection of structurally related ligand scaffolds.

Fig. 3.

Fig. 3

Addition of ZnEt2 to an equimolar mixture of (S,S)-5 and (R,R)-5 leads to formation of the heteroleptic complex SAL Zn(STRT).

The hydroxyl functionalities residing in tethers ST and RT serve as convenient attachment points for the ligating group subunits. In doing so, combining (S,S)- and (R,R)-box derivatives bearing chiral phosphite terminated tethers A-P (i.e., assembling the recognition, scaffold-building and ligating group subunits) enables the facile preparation of hundreds of chiral bidentate, self-assembled ligands (i.e., SAL Zn(STRT)) differing in the combination of scaffold-building tethers, ST and RT.57The metal ultimately responsible for catalysis, Mcat, is the active site subunit. Combining Mcat with each SAL Zn(STRT) affords a series of supramolecular catalysts 4, each possessing a different catalyst scaffold. In the present study of asymmetric hydrogenation, the ligating group is restricted to a chiral phosphite (principally, the BINOL-dervied phosphite) and the catalytic metal limited to Rh(I) (for the most part as its tetrafluoroborate salt).

The supramolecular catalysts defined by structure 4 offer the potential to tune catalyst activity by making a large number of subtle changes to the ligand/catalyst scaffold, an approach that typically is challenging using the more traditional approaches to catalyst design in Figure 1. A preliminary investigation into rhodium-catalyzed asymmetric hydrogenations (CAH) of dehydroaminoacid derivatives using a series of SALs bearing chiral (R)-5,5’,6,6’-tetramethylbiphenyl-2,2’-diol (BIPHEP) derived phosphite ligating groups, i.e., (BIPHEP)SAL Zn(STRT), was previously reported.58 Herein, we focus on results obtained using in situ generated (BINOL)SAL Zn(STRT) ligands in combination with Rh(nbd)2BF4 for the rhodium-catalyzed asymmetric hydrogenations of two prototypical substrates, S1 and S2 (Figure 4).59 Analysis of the data reveals the extent to which each catalyst subunit influences the efficiency of the supramolecular catalyst.

Fig. 4.

Fig. 4

General conditions employed for rhodium-catalyzed asymmetric hydrogenation of two prototypical substrates.

Influence of the Ligating Group Subunit

As expected, the nature of the ligating group (i.e., 4, subunit II) directly bound to the site of reaction plays a very important role in determining the catalyst efficiency. The phenyl and benzyl monophosphites derived from TADDOL, BIPHEP, and BINOL diols (i.e., L1a/b–L3a/b) can be thought of as simplified, unconstrained model ligands for comparison to the corresponding SAL-derived supramolecular catalyst systems 4. In particular, the phenyl phosphites serve as models for the SALs derived from subunits A–H, benzyl phosphites for those SALs incorporating tether subunits I–P. Hydrogenation of S1 and S2 (Table 1) using the (R)-TADDOL-derived monophosphites (i.e., L1a and b) give only low levels of enantioselectivity under the conditions shown above (4-30% ee, Table 1 entries 1 & 2). The corresponding (R)-BIPHEP derivatives give moderate levels of enantioselectivity, 53-67% ee (entries 3 & 4) with the phenyl phosphite 2a giving higher selectivity. The (R)-BINOL phosphites L3a and b give still higher levels of enantioselectivity (69-92% ee), and in each case, the reaction affords near quantitative yield of the hydrogenated product (entries 5 & 6).60 The BINOL phosphites, however, are more successful with substrate S1 than with S2, and in contrast to the BIPHEP derivatives, the BINOL-derived benzyl phosphite L3b affords higher ee than the phenyl phosphite L3a. For the purpose of comparison to the results obtained with certain of the SALs presented below, it should be noted that the mixed ligand combination,61-62 that is, using equimolar amounts of L3a and L3b, gives 92% and 78% ee for substrates S1 and S2, respectively.

Table 1.

Rhodium-catalyzed asymmetric hydrogenation of S1 and S2 using model phosphite ligands.a

graphic file with name nihms421355u1.jpg
S1 S2
Entry Ligand ee (%)b yld (%) ee (%)b yld (%)
1 L1a 10 99 4 97
2 L1b 15 99 30 99
3 L2a 67 99 67 99
4 L2b 53 99 53 65
5 L3a 86 99 69 99
6 L3b 92 99 78 99
7 L3a + L3bc 92 99 78 99
8 L4a 26 93 20 99
9 L4b 68 90 87 99
10 L4c 64 87 71 99
11 L4d 43 99 13 90
a

Reaction conditions: 1 mol% Rh(nbd)2BF4, 2.1 mol% monophosphite, or 1.1 mol% SAL Zn(STRT), H2 (30 psi), DCE, rt, 16 h. Yields and enantioselectivity determined by chiral GC using N-benzylacetamide as an internal standard.

b

Unless otherwise noted, the (S)-enantiomer predominates in the reaction.

c

Equimolar amounts of each ligand.

The chiral monodentate ligands discussed above provide benchmarks for the effectiveness of chiral phosphite ligating groups lacking any connecting scaffold. To benchmark the effectiveness of a relatively non-structured ligand scaffold, a series of BINOL-bisphosphites (L4a–d) were prepared from 1,n-diols.63 These simple bisphosphites, spaced by 3 to 6 methylene units, varied widely in their effectiveness. Enantioselectivity ranged from 26–68% ee for the reactions of S1 and from 13–87% ee for the reaction of S2 (entries 8–11). Only one combination, the reaction of S2 using the 1,4-butane diol derived L4b, gives product in higher enantiomeric excess, albeit only incrementally higher, than the best monophosphite, that is, 87% versus 78% ee (Table 1, compare entry 9 to entry 6).

BINOL-bisphosphite SALs, i.e., (BINOL)SAL Zn(STRT), were prepared from combinations of tether subunits A–P by treating the appropriate (S,S)- and (R,R)-5 box derivatives with Et2Zn.64 Each SAL was subsequently combined with Rh(nbd)2BF4 to effect the in situ preparation of over 165 closely related supramolecular catalysts, each bearing the same two (BINOL)P-ligating groups but differing in the catalyst scaffold. The results obtained as a function of scaffold are discussed in detail below. However, among the scaffolds tested, (BINOL)SAL Zn(IC) affords the highest level of enantioselectivity for both S1 and S2, giving 96% and 93% ee, respectively (Table 2, entry 3). These levels of enantiomeric excess are higher than those obtained using L3a (S1 86% ee; S2 69% ee), L3b (S1 92% ee; S2 78% ee) or any obtained using the bisphosphites bearing flexible scaffolds, i.e., L4a–d (Table 1, entries 8-11). (BINOL)SAL Zn(IC) contains one benzyl-like (ArCH2O-linked) phosphite and one phenyl-like (ArO-linked) phosphite within its structure and thus, the mixed combination of monophosphites L3a/b (Table 1 entry 7, S1 92% ee; S2 78% ee) is perhaps the most relevant performance benchmark for comparison.65

Table 2.

Influence of the ligating group on the performance of SAL scaffold Zn(IC).

graphic file with name nihms421355u2.jpg
S1 S2
Entry Ligand ee (%) yld (%) ee (%) yld (%)
1 (TADDOL)SAL Zn(IC) 31 68 -- NR
2 (BIPHEP)SAL Zn(IC) 23 76 25 21
3 (BINOL)SAL Zn(IC) 96 99 93 99
4 L5 (2.1 equiv) 65 13 30 2
5 L6 (2.1 equiv) 92 99 85 99
a

Reaction conditions: 1 mol% Rh(nbd)2BF4, 1.1 mol% SAL Zn(STRT) or 2.1 mol% monophosphite, H2 (30 psi), DCE, rt, 16 h. Yields and enantioselectivity determined by chiral GC using N-benzylacetamide as an internal standard. Unless otherwise noted, the (S)-enantiomer predominates.

Table 2 compares the results obtained using (TADDOL)SAL Zn(IC) (entry 1) and (BIPHEP)SAL Zn(IC) (entry 2) to those obtained with (BINOL)SAL Zn(IC) (entry 3). The results demonstrate the significance of the ligating group on the performance of the supramolecular catalyst. The TADDOL- and BIPHEP-derived SALs with the same catalyst scaffold exhibit low reactivity and only low levels of enantioselectivity. The differences between the performance of (BIPHEP)SAL Zn(IC) and (BINOL)SAL Zn(IC) are particularly striking and surprising in light of the structural similarities of the two ligating groups and the results obtained with monophosphites L2a and L3a. In contrast, (BIPHEP)SAL Zn(IC) and (BINOL)SAL Zn(IC) differ significantly in terms of yield (21–76% versus 99%) and enantioselectivity (23–25% ee versus 93–96% ee). The truncated models of (BINOL)SAL Zn(IC), L5 and L6, serve as control experiments showing that the ligating group alone is not sufficient for optimal performance. Note that the results obtained with L6 are essentialy the same as those obtained using L3b (see Table 1).

In summary, since the ligating group is the chiral element directly bound to rhodium and closest to the reacting substrate, its critical importance in determining reactivity and selectivity is of course expected. The yield and enantioselectivity data comparing mono- to bisphosphites show that a conformationally mobile tether (L4a–L4d) is usually detrimental compared to the monophosphite and only occasionally results in comparable or modestly enhanced catalyst performance. While catalyst efficiency was found to be optimized with a more highly structured bisphosphite scaffold (i.e., (BINOL)SAL Zn(IC)), the high levels of reactivity and selectivity are intimately tied to the combination of scaffold and ligating group. Attaching other ligating groups to the same scaffold do not necessarily enhance catalyst performance over that of the corresponding monophosphites; this is shown to be the case with TADDOL- and BIPHEP-derived bisphosphites.

Influence of the Ligand/Catalyst Scaffold

The various tether subunits shown in Figure 1 were combined with Et2Zn and Rh(nbd)2BF4 to effect the in situ preparation of 169 closely related supramolecular (BINOL)SAL Zn(STRT) catalysts. Each supramolecular catalyst bears the same two (BINOL)P-ligating groups but differ in the ligand/catalyst scaffold. Each catalyst was screened individually in the asymmetric hydrogenation of substrate S1 under a standard set of reaction conditions. The data are analyzed in several ways as discussed in the paragraphs that follow.

The plot in Figure 5 compiles the stereochemical results; these data are simply sorted from low levels of enantioselectivity to high without regard to scaffold structure. As discussed above, the most selective catalyst, (BINOL)SAL Zn(IC), affords S-2a in 96% ee. The plot can be divided into three regions: (1) a flat region representing a group of approximately 11 catalysts that afford racemic product; (2) a group of roughly 50 catalysts whose performance spans a wide range from racemic to greater than 80% ee; and (3) a large plateau region comprised of data for 106 catalysts whose behaviour varies within a realitively narrow range (87–96% ee). Thus, the effects of subtle differences in the structure of the catalyst scaffold run the gamet, some markedly influence catalyst selectivity while the effects of others are only incremental.

Fig. 5.

Fig. 5

Observed enantioselectivity for the CAH of S1 sorted from high to low as a function of catalyst scaffold (BINOL)SAL Zn(STRT). The yellow data points incorporate only tethers C–G, the blue only I–P, and the green for mixed combinations of (C–G) with (I–P).

The data in Figure 5 can be further analyzed in terms of scaffold structure. The individual data points in Figure 5 are color coded. Those highlighted in yellow represent supramolecular catalyst scaffolds incorporating only tethers C–G (that is, only ArO-P(BINOL) linkages), those in blue only I–P (i.e., only ArCH2O-P(BINOL) linkages), and those in green represent mixed combinations of (C–G) with (I–P). Looking more closely at the data, the yellow data points tend to cluster towards the low end of the percent enantiomeric excess range. Only a few scaffolds containing only combinations of ArO-linkages to the BINOL-phosphite ligating group are as selective as the model phenyl monophosphite 3a. Thus, it seems that the constraints imposed by the scaffold detract from the effectiveness of the ligating group for these derivatives. On the other hand, supramolecular catalysts bearing only ArCH2O-linkages (the blue data points) tend to dominate the high end plateau region; that is, they show little variation in performance as a function of the catalyst scaffold. The observed enantioselectivities for those catalysts are rather tightly clustered around that obtained with the model benzyl monophosphite 3b. The green data points representing mixed ArO- and ArCH2O-linkages are spread more evenly throughout the range of catalyst performance, from racemic to 96% ee.

In screening the supramolecular catalysts, all reactions are run under a standard set of reaction conditions, and in addition to R/S ratios, the product yield was determined by comparison to an internal GC standard. Not all catalysts effect complete consumption of starting material under the conditions employed indicating their relatively low reactivity or susceptibility toward catalyst inactivation. This is in stark contrast to the quantitative conversion observed using BINOL monophosphite ligands L3a–L3b (Table 1, entries 5–6). Plotting percent enantiomeric excess versus percent yield shows that catalyst turnover is also systematically affected by the scaffold structure (Figure 6).66 Graph A summarizes all of the data with the individual data points again color coded by tether combination. The upper right hand quadrant (labeled IV) represents catalysts for which the yield and enantioselectivity are 70% or greater. This perspective of the data reveals a number of interesting trends. First, the high yield-high enantioselectivity quadrant IV is rather densely populated. Nonetheless, a significant number of catalysts, as represented in the upper left hand quadrant I, give relatively high enantiomeric excess but only moderate-to-low yield. That is, a number of catalysts are quite selective but exhibit slow turnover or are prone to deactivation. In contrast, relatively few catalysts populate the lower right hand quadrant III, that is, catalysts that exhibit average or better turnover frequency but low enantioselectivity.67

Fig. 6.

Fig. 6

Plot of catalyst performance (% ee versus % yield) in the CAH of S1 coded by tether combination: Graph A – overall data set for all catalysts screened (note that some points are obscured by overlapping data); Graph B – Quadrant IV data only (% ee and % yield greater than 70%) for all catalysts combinations of only tethers I–P; and Graph C – Quadrant IV data only (% ee and % yield greater than 70%) for catalysts combinations of tethers C–G with tether I–P.

Focusing on the ArO- or ArCH2O-linkage within each catalyst, data in Figure 6 show that catalyst scaffolds containing only ArO-phosphite linkages (i.e., yellow data points) tend to be more highly represented among those catalysts giving lower yield, lower enantioselectivity, or both (quadrant II). In contrast, few blue data points, that is, those representing only ArCH2O-phosphite linkages, lie outside the high yield-high enantioselectivity quadrant. Those catalysts containing a combination of ArO- and ArCH2O-linkages, represented by the green data points, tend to be quite varied in their performance.

The smaller plots within Figure 6 give separate expanded stack plots for the high yield-high enantioselectivity quadrant IV catalysts; only ArCH2O-linkage data are shown in Graph B with the mixed linkage data presented in Graph C. These views support the conclusion that the performance of mixed-linkage catalysts is more sensitive to the precise structure of the scaffold while the benzyl-only linked catalysts are not as readily fine-tuned by scaffold modification. One possible explanation for the difference between the ArCH2O-only linkage and mixed linkage catalysts is that, aside from subtle electronic differences, the additional degree of rotational freedom afforded to the former tends to work against subtle structural changes in the scaffold translating to measureable changes in the chiral topography.

Having examined overall trends in the data summarized above, Figure 7 highlights the empirically identified “best” scaffold structure, (BINOL)SAL Zn(IC), and how subtle structural changes effect catalyst performance. Having arrived at a structural “sweet-spot” with (BINOL)SAL Zn(IC), it is perhaps somewhat surprising to find that subtle changes to that structure result in only small changes in catalyst performance. For example, comparing (BINOL)SAL Zn(IC) to the isomeric (BINOL)SAL Zn(JC) or to the one-carbon-homologated (BINOL)SAL Zn(IK), one finds little change in catalyst performance; the observed yields (99%) and enantioselectivity (93–96% ee and 90–93% ee for substrates S1 and S2, respectively) remain high for each catalyst. Other structural changes have a somewhat more significant, albeit still incremental, effect. The isomeric SALs in which the phenyl phosphite linkage is 1,3 or 1,4 (i.e., (BINOL)SAL Zn(IE) and (BINOL)SAL Zn(IG)) rather than 1,2 as in (BINOL)SAL Zn(IC), or when the arene attached to the box moiety is 1,4 rather than 1,3 (i.e., (BINOL)SAL Zn(ID) all afford somewhat less efficient catalysts (i.e., 85–91% ee and 86–89% ee for substrates S1 and S2, respectively).

Fig. 7.

Fig. 7

Illustrating the largely incremental effect of varying the structure of the empirically determined optimal catalyst scaffold.

Table 3 compares a more extensive set of structures differing in the 1,2-, 1,3- and 1,4-substitution pattern defining (S,S)-5 (i.e., ST) coupled with two closely related subunits defined by (R,R)-5 (i.e., RT = G and O). The Table compares data for catalysts incorporating only ArO-linkages (entries 1–3), mixed combinations (entries 4–9) and only ArCH2O-linkages (entries 10–12). Within this series we see considerably more variation in catalyst performance, yet the data otherwise tend to reinforce the trends discussed above. Catalysts bearing only ArO- linkages (entries 1–3) tend to give lower enantioselectivity and a wider range of yield than other combinations. For example, compare entries 1–3 (60–68% ee, 22–95% yield) to entries 4–9 (70–94% ee, 88–99% yield) and entries 10–12 (88-93% ee, 78–99% yield).

Table 3.

Relatively small changes in the structure of a large supramolecular catalyst can in some cases significantly influence the reactivity and enantioselectivity in the CAH of S1.

graphic file with name nihms421355u3.jpg
Entry (BINOL)SAL Zn(STRT) X1 X2 ee (%)b yld (%)
1 CG O O 60 22
2 EG O O 68 28
3 GG O O 67 95
4 KG CH2O O 85 90
5 MG CH2O O 82 88
6 OG CH2O O 94 99
7 CO O CH2O 70 99
8 EO O CH2O 87 99
9 GO O CH2O 93 99
10 KO CH2O CH2O 89 88
11 MO CH2O CH2O 89 78
12 OO CH2O CH2O 93 99
a

Reaction conditions: 1 mol% Rh(nbd)2BF4, 1.1 mol% (BINOL)SAL Zn(STRT), H2 (30 psi), DCE, rt, 16 h. Yields and enantioselectivity determined by chiral GC using N-benzylacetamide as an internal standard.

b

Unless otherwise noted, the (S)-enantiomer predominates in the reaction.

Examining the data in Table 3 in more detail reveals interesting contrasts. Compare the results obtained with (BINOL)SAL Zn(OG) (entry 6, 94% ee, 99% yield) to two close analogues. (BINOL)SAL Zn(GG) differs in structure by the absence of just one methylene unit but is decidedly less enantioselective (entry 3, 67% ee, 95% yield). In contrast, its homologue (BINOL)SAL Zn(OO) differs by the inclusion of one additional methylene unit and performs nearly the same as the optimal catalyst (entry 12, 93% ee, 99% yield).

In summary, as suggested above in the discussion on the influence of the ligating group, the precise structure and nature of the tether subunit can play an important role in the efficiency of the reaction catalyzed by these supramolecular catalysts. Subtle structural changes can, but do not always, have a big effect on enantioselectivity, yield, or both. The data suggest that a balance between key elements of rigidity and flexibility is required for the successful catalysts and, moreover, that balance is required to enable effective fine-tuning via catalyst scaffold optimization.68 Without sufficient rigidity, subtle changes in the scaffold structure are relatively ineffective for catalyst optimization; the same holding true in cases lacking sufficient flexibility.

Perhaps the most surprising finding is that for the systems studied, subtle changes around the empirically determined “structural sweet spot” tend to have only small incremental effects on catalyst performance. This may reflect the capacity of a macrocyclic chelate to accomodate small changes in structure without requiring significant changes to its overall three-dimensional shape.

Influence of the Recognition Element Subunit

The nominal structures of all supramolecular catalysts examined in this study are quite similar by design, and many are isomeric with one another by virtue of subtle differences in tether subunit substitution patterns. However, only a subset of structures differ in one rather subtle way involving the recognition element subunit rendering them diastereomeric. For example, consider the structures of (BINOL)SAL Zn(OG) and (BINOL)SAL Zn(GO) generated from combinations of (S,S)-5O with (R,R)-5G and (S,S)-5G with (R,R)-5O, respectively. These ligands differ only by the interchange of the two tether subunits appended to the box-zinc complex. The core ((S,S)-box)Zn(R,R-box) recognition subunit that directs heteroleptic self-assembly has the element of inversion symmetry.55 That symmetry element is lost when chiral ligating groups are appended to the core. Consequently, (BINOL)SAL Zn(OG) and (BINOL)SAL Zn(GO) are diastereomers. Their derived supramolecular catalysts therefore need not exhibit the same reactivity or selectivity; however, the box substituents are seemingly far removed from the site of catalysis (i.e., the Rh center), and we initially assumed any difference in catalyst performance would be insignificant.

It indeed often proves to be the case that similar reactivity and selectivity is exhibited by pairs of diastereomeric catalysts. For example, the diastereomeric (BINOL)SAL Zn(OG)- and (BINOL)SAL Zn(GO)-derived catalysts give nearly identical results ((see Table 2, entries 6 and 9: quantitative yield, 93–94% ee). However, this is not always the case; for example, (BINOL)SAL Zn(IC) and its diastereomer (BINOL)SAL Zn(CI) (Figure 6) exhibit quite different catalyst performance, 96% versus 87% ee. The graph in Figure 8 plots the well-known relationship between percent enantiomeric excess and the difference in activation energies for the reactions leading to (S)- and (R)-products (i.e., ΔΔG(S/R)). For the catalysts derived from (BINOL)SAL Zn(IC) and (BINOL)SAL Zn(CI), the difference in enantioselectivity (Δes) translates to an estimated 0.73 Kcal/mol [difference in (ΔΔG(R/S))] for the diastereomeric catalysts.

Fig. 8.

Fig. 8

Theoretical relationship between enantioselectivity and the difference in (ΔΔG (R/S)); diastereomeric catalysts can afford a large difference in enantioselectivity defined as Δes.

In addition to differences in enantioselectivity, some pairs of diastereomeric catalysts exhibit significant differences in the chemical yield obtained under the standard reaction conditions suggesting significant differences in catalyst turnover rates and/or catalyst deactivation. Figure 9 plots the difference in enantioselectivity (Δes, expressed in kcal/mol) versus the increase or decrease in percent yield for the 78 pairs of diastereomeric catalyst combinations evaluated.

Fig. 9.

Fig. 9

Differences in yield and enantioselectivity between 78 pairs of diastereomeric catalysts in the CAH of S1, (BINOL)SAL Zn(STRT), as revealed by a plot of Δes (kcal/mol) versus the increase or decrease in percent yield obtained for the more selective of the diastereomeric catalysts. The yellow points incorporate only tethers C–G in the catalyst scaffold, the blue only I–P, and the green are for mixed combinations of (C–G) with (I–P).

Most diastereomeric catalysts, especially those bearing only ArCH2O-linkages (data in blue), exhibit relatively small differences in enantioselectivity and yield. This is consistent with the idea that in most cases the box moieties exert little influence on what occurs at the site of reaction (i.e. at rhodium). However, others show rather striking matched/mismatched behavior suggesting that the recognition subunit along with the tethers that make up the catalyst scaffold significantly impact catalyst efficiency. This is especially true for scaffolds bearing mixed phenyl/benzyl linkages (data in green) and to a lesser extent those bearing only phenyl-type linkages (data in yellow). The data also suggest that increased enantioselectivity is more frequently accompanied by improved rather than diminished yield when comparing these diastereomeric catalyst pairs.

Data for several of the more striking cases of matched/mismatched behavior are summarized in Table 4. (BINOL)SAL Zn(LC) (entry 3) and its diastereomeric scaffold (BINOL)SAL Zn(CL) are another example in which the two catalysts have similar reactivity but a significant difference in enantioselectivity. Many catalyst pairs exhibit a drop in enantioselectivity in conjunction with a drop in reactivity for one of their diastereomers, for example, (BINOL)SAL Zn(NG) and (BINOL)SAL Zn(GN) (entry 4). In a few extreme cases, for example, (entries 5 & 6), the diastereomeric scaffold is completely ineffective. In constrast, (BINOL)SAL Zn(JF) and (BINOL)SAL Zn(FJ) (entry 7) represent a case where the change in scaffold only affects reactivity. The examples discussed above are ones for which the scaffold has a combination of ArCH2O-and ArO-linkages. For most of the scaffolds containing only ArCH2O-linkages, both diastereomers exhibit high reactivity and selectivity; however, there are exceptions. For example, entries 8 and 9 are among the diastereomers that exhibit rather pronounced differences in the selectivity. Diastereomeric scaffolds bearing only ArO-linkages generally differ substantially as illustrated by entries 10 and 11.

Table 4.

Several striking cases in which pairs of diastereomeric (BINOL)SAL Zn(STRT) catalysts exhibit matched/mismatched reactivity and/or enantioselectivity in the CAH of substrate of S1.

Entry Zn (STRT) %ee (%yld) Zn (STRT) %ee (%yld) Δes (kcal/mol)
1 OG 94 (99) GO 93 (99) 0.09
2 IC 96 (99) CI 87 (99) 0.73
3 LC 94 (99) CL 86 (93) 0.53
4 NG 90 (99) GN 90 (58) 0
5 LD 92 (96) DL 0 (23) 1.88
6 FP 90 (85) PF nr --
7 JF 92 (98) FJ 37 (10) 1.42
8 KL 94 (94) LK 86 (99) 0.58
9 KM 92 (87) MK 74 (99) 0.55
10 EG 84 (99) GE 68 (28) 0.46
11 EC 84 (94) CE 75 (85) 0.29
a

All examples gave predominately the (S)-enantiomer.

In summary, among the subunits that comprise the structures for a series of hetereobimetallic catalysts represented by 4, the significant influence of the recognition elements (subunit IV) on reactivity and/or selectivity is perhaps the most surprising. While the observed differences are difficult to rationalize at present, much less predict, the results summarized in Figure 9 and Table 4 suggest that the zinc-bisoxazoline complex plays a structural role that goes beyond chirality directed self-assembly and beyond that of simply connecting the tethers. Instead, it seems that at least in some cases, the recognition subunit strongly influences the organization of the tethers and ligating groups and/or directly interacts with the substrate during the course of the reaction.

Conclusions

Approaches to supramolecular catalyst systems that utilize hydrogen-bonding or metal complexation directed self-assembly to organize chirality and define the topography of the chemical active site are of interest in part because such chemocatalysts are conceptually linked to biocatalysts. While significant progress has been reported toward understanding how to design and optimize catalyst performance using classical, small-molecule catalyst design motifs, much less is known on how to optimize the performance of supramolecular catalysts. An important underlying question is whether hydrogen bonding and metal complexation strategies used in the design of supramolecular catalysts offer significant advantages compared to classical approaches to asymmetric catalyst design.

One potential advantage of the supramolecular catalysts defined by structure 4 is that combinatorial methods can be employed to facilitate modular ligand/catalyst synthesis and used to probe the effectiveness of catalyst scaffold optimization. Furthermore, forming macrocyclic chelated catalysts (i.e., 4), rather than smaller, more rigid chelates or organization through non-bonded interactions, seemingly allow for the smoother incremental variation in catalyst. However, as it the case with all protocols designed to effect structure optimization via a combinatorial approach, the approach is only likely to prove useful if the subunits varied combinatorially adequately explore the relevant chemical space.

In this study of structure-activity and structure-selectivity relationships of a modular supramolecular hydrogenation catalyst system, a series of BINOL phosphite derived SALs were used to prepare a series of supramolecular catalysts in situ which were evaluated in the rhodium-catalyzed asymmetric hydrogenations of two prototypical enamide substrates. The catalysts vary widely in their reactivity and enantioselectivity. Although there are exceptions, the data suggest that a balance between key elements of rigidity and flexibility is required for the successful catalysts and, moreover, that balance is required to enable effective fine-tuning via catalyst scaffold optimization. Without sufficient rigidity, subtle changes in the scaffold structure are relatively ineffective for catalyst optimization; the same holding true in cases lacking sufficient flexibility.

SALs bearing only the more flexible ArCH2O-linkages are with few exceptions active and give high enantioselectivity; 58 examples of such catalysts give an average of 98% yield and 90.2% ± 3.8% ee. In constrast, those SALs bearing only more constrained ArO-linked phosphite on average give much lower lower yield and enantioselectivity under the screening conditions; 20 catalysts give an average 23% yield and 22% ee. Nearly all attempts to optimize the catalyst scaffold with SALs bearing only more constrained ArO-linked phosphite failed in comparison to the monodentate model ligand, (BINOL)POPh (L3a); the latter affords quantitative conversion of the product with good enantioselectivity (69–86% ee). Although it is possible that subtle electronic factors serve to differentiate the ArCH2O- and ArO-linked SALs studied, it seems more likely that the additional rotational degrees of freedom afforded to the former play a significant role in the catalyst efficiency.

Those catalysts bearing a combination of ArCH2O- and ArO-linkages exhibit the widest range of performance and include the overall best performing catalyst, (BINOL)SAL Zn(IC). Nonetheless, their average yield and level of enantioselectivity fall between those obtained with ArCH2O-only and ArO-only catalysts; 80 catalysts bearing mixed linkages give an average 72% yield and 77% ee. Nonetheless, while the change in catalyst performance as a consequence of subltle changes in the catalyst scaffold can be quite significant, subtle changes in the empirically determined optimal scaffold structure generally have only an incremental effect.

Among the four structural subunits (recognition subunit, scaffold-generating tether subunits, ligating group subunits, and catalytic metal subunit), it is perhaps most unexpected to find that the recognition subunit can play an important role in influencing reactivity. A significant number among the pairs of diastereomeric catalysts exhibit matched/mismatched relationships. Given the structure and local symmetry (inversion symmetry) of the recognition element, we find it difficult to rationalize the matched/mismatched results solely on the basis of a remote conformational change propagated to the chiral ligating groups. Future studies will explore whether secondary interactions with the macrocyclic catalyst scaffold play an important role in determining catalyst efficiency and thereby help explain how a series of closely related supramolecular catalysts, each bearing essentially the same two BINOL-phosphite ligating groups complexed to Rh(I), exhibit such a wide range of reactivity and selectivity.

It should be emphasized that, while the findings described above may have some general applicability at a conceptual level, the specific details and trends noted above are relevant only to the specific reaction investigated (i.e., rhodium-catalyzed asymmetric hydrogenation reaction and its unique structural and mechanistic requirements); the details for other catalysts and/or reactions may and in some cases do differ.69

Experimental Procedure

The following procedure is typical. To a solution of BINOL tether ((S,S)-5I) (3.7 mg, 5.1 μmol) and BINOL tether ((R,R)-5C) (3.8 mg, 5.1 μmol) in dicloromethane (DCM, 1.0 mL) was added a solution of diethyl zinc (0.10 mL, 5.6 μmol) dropwise and 3 2 mm glass beads. The resulting mixture was stirred on an orbital shaker (ca 125 revolutions/min) for 30 minutes and then concentrated in vacuo to afford (BINOL)SAL Zn(IC) which was diluted with dichloroethane (DCE, 2.0 mL) and used without further purification. A solution of Rh(nbd)2BF4 (1.9 mg, 5.1 μmol) in DCM (0.20 mL) was added dropwise and the resulting mixture was stirred for 30 minutes at ambient temperature under N2. A solution of N-(1-(4-chlorophenyl)vinyl)acetamide (S1) (1.0 × 102 mg, 5.1 × 102 mmol) in DCE was then added and the vial was placed into a hydrogenated chamber. The chamber was purged with hydrogen gas (5 × 20 psi) and then pressurized to 30 psi H2 and lightly shaken (ca 125 revolutions/minute) at ambient temperature for 16 hours. The hydrogen pressure was released, and the crude reaction mixture was concentrated and purified by flash chromatography on silica gel using EtOAc/Hexanes (1:5) as the eluent yielding (S)-N-(1-(4-chlorophenyl)ethyl)acetamide (98% yield) as a white solid: gas chromatography on a CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a temperature program of 140–200°C at 1°C/min) show 95% ee; [α]D = -152 (c = 0.5, EtOH); literature, [α]D= -154 (c = 0.5, EtOH, 96% ee)70-72; 1H NMR (400 MHz, CDCl3) δ7.33-7.25 (4H, m), 5.76 (1H, bs), 5.11 (1H, m), 2.00 (3H, s), 1.48 (3H, d, J = 6.92 Hz); 13C NMR (100 MHz) δ 169.11, 141.79, 133.06, 128.77, 127.58, 48.20, 23.41, 21.69.

Supplementary Material

1_si_001
2_si_002

Acknowledgments

Acknowledgment is made to the Donors of the American Chemical Society Petroleum Research Fund for partial support of this research (PRF 47257-AC1) and to the NSF (CHE-0809637), NIH (STTR R41 GM074337) and Nebraska Research Initiative for their support. We thank K. Chaiseda and R. Verduzzo for some preliminary studies, and the NSF (CHE-0091975, MRI-0079750) and NIH (SIG-1-510-RR-06307) for the NMR spectrometers used in these studies carried out in facilities renovated under NIH RR016544.

Footnotes

Supporting Information Available

Full asymmetric hydrogenation data table, experimental procedures and spectral characterization of key ligands and products. This material is available free of charge via the internet at http://pubs.acs.org/.

Notes and references

  • 1.Vineyard BD, Knowles WS, Sabacky MJ, Bachman GL, Weinkauff OJ. J Am Chem Soc. 1977;99:5946–5952. [Google Scholar]
  • 2.Knowles WS. Acc Chem Res. 1983;16:106–112. [Google Scholar]
  • 3.Knowles WS. Angew Chem Int Ed. 2002;41:1998–2007. [Google Scholar]
  • 4.Pena D, Minnard AJ, de Vries JG, Feringa BL. J Am Chem Soc. 2002;124:14552–14553. doi: 10.1021/ja028235t. [DOI] [PubMed] [Google Scholar]
  • 5.Reetz MT, Mehler G. Angew Chem Int Ed. 2000;39:3889–3890. doi: 10.1002/1521-3773(20001103)39:21<3889::AID-ANIE3889>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  • 6.van den Berg M, Minnard AJ, Schudde EP, van Esch J, de Vries AHM, de Vries JG, Feringa BL. J Am Chem Soc. 2000;122:11539–11540. [Google Scholar]
  • 7.Zhang F, Li Y, Li ZW, He YM, Zhu SF, Fan QH, Zhou QL. Chem Commun. 2008:6048–6050. doi: 10.1039/b815380a. [DOI] [PubMed] [Google Scholar]
  • 8.Jerphagnon T, Bruneau C. Tetrahedron: Asymmetry. 2004;15:2101–2111. [Google Scholar]
  • 9.Breit B. Angew Chem Int Ed. 2005;44:6816–6825. doi: 10.1002/anie.200501798. [DOI] [PubMed] [Google Scholar]
  • 10.Ringe D, Petsko GA. Science. 2008;320:1428–1429. doi: 10.1126/science.1159747. [DOI] [PubMed] [Google Scholar]
  • 11.Carboni S, Gennari S, Pignataro L, Piarulli U. Dalton Trans. 2011;40:4355–4373. doi: 10.1039/c0dt01517b. [DOI] [PubMed] [Google Scholar]
  • 12.Deuss PJ, den Heeten R, Wouter L, Kamer PCJ. Chem Eur J. 2011;17:4680–4698. doi: 10.1002/chem.201003646. [DOI] [PubMed] [Google Scholar]
  • 13.Wiester MJ, Ulmann PA, Mirkin CA. Angew Chem Int Ed. 2010;50:114–137. doi: 10.1002/anie.201000380. [DOI] [PubMed] [Google Scholar]
  • 14.Gasparini G, Molin MD, Prins LJ. Eur J Org Chem. 2010;13:2429–2440. [Google Scholar]
  • 15.van Leeuwen PWNM. Supramolecular Catalysis. Wiley-VCH; Weinheim: 2008. [Google Scholar]
  • 16.Ballester P, Vidal-Ferran A, van Leeuwen PWNM. Modern Strategies in Supramolecular Catalysis. In: Gates BC, Knözinger H, Jentoft F, editors. Advances in Catalysis. Vol. 54. Academic Press; UK: 2011. pp. 63–126. [Google Scholar]
  • 17.Reyes SJ, Burgess K. Chem Soc Rev. 2006;35:416–423. doi: 10.1039/b516721n. [DOI] [PubMed] [Google Scholar]
  • 18.Karakhavanov EA, Maksimiov AL, Runova EA. Russ Chem Rev. 2005;74:97–111. [Google Scholar]
  • 19.Hofacker A, Parquette JR. Proc R Soc A. 2010;466:1469–1487. [Google Scholar]
  • 20.Shao H, Seeifert J, Romano NC, Helmus JJ, Jaroniec CP, Modarelli A, Parquette JR. Angew Chem Int Ed. 2010;49:7688–7691. doi: 10.1002/anie.201003415. [DOI] [PubMed] [Google Scholar]
  • 21.Yu J, RajanBabu TV, Parquette JR. J Am Chem Soc. 2008;130:7845–7847. doi: 10.1021/ja802308a. [DOI] [PubMed] [Google Scholar]
  • 22.Mes T, van der Weegen R, Palmans ARA, Meijer EW. Angew Chem Int Ed. 2011;50:5085–5089. doi: 10.1002/anie.201100104. [DOI] [PubMed] [Google Scholar]
  • 23.Dong Z, Plampin JN, III, Yap GPA, Fox JM. Org Lett. 2010;12:4002–4005. doi: 10.1021/ol101583v. [DOI] [PubMed] [Google Scholar]
  • 24.Bauer G, Benkő Z, Nuss J, Nieger M, Gudat D. Chem Eur J. 2010;16:12091–12095. doi: 10.1002/chem.201001414. [DOI] [PubMed] [Google Scholar]
  • 25.Chikkali SH, Nieger M, Gudat D. New J Chem. 2010;34:1348–1354. [Google Scholar]
  • 26.Chikkali SH, Gudat D, Lissner F, Niemeyer M, Schleid T, Nieger M. Chem Eur J. 2009;15:482–491. doi: 10.1002/chem.200801517. [DOI] [PubMed] [Google Scholar]
  • 27.Gadzikwa T, Bellini R, Dekker HL, Reek JNH. J Am Chem Soc. 2012;134:2860–2863. doi: 10.1021/ja211455j. [DOI] [PubMed] [Google Scholar]
  • 28.Bokokić V, Lutz M, Spek AL, Reek JNH. Dalton Trans. 2012;41:3740–3750. doi: 10.1039/c2dt12096h. [DOI] [PubMed] [Google Scholar]
  • 29.Bellini R, Chikkali SH, Berthon-Gelloz G, Reek JNH. Angew Chem Int Ed. 2011;50:7342–7345. doi: 10.1002/anie.201101653. [DOI] [PubMed] [Google Scholar]
  • 30.Goudriaan PE, Jang XB, Kuil M, Lemmens R, Van Leeuwen PWNM, Reek JNH. Eur J Chem. 2008:6079–6092. [Google Scholar]
  • 31.Jiang XB, Lefort L, Goudriaan PE, de Vries AHM, van Leeuwen PWNM, de Vries JG, Reek JNH. Angew Chem Int Ed. 2006;45:1223–1227. doi: 10.1002/anie.200503663. [DOI] [PubMed] [Google Scholar]
  • 32.Van Leuuwen PWNM, Rivillo D, Raynal M, Freixa Z. J Am Chem Soc. 2011;133:18562–18565. doi: 10.1021/ja207912d. [DOI] [PubMed] [Google Scholar]
  • 33.Goudriaan PE, Kuil M, Jiang XB, van Leeuwen PWNM, Reek JNH. Dalton Trans. 2009:1801–1805. doi: 10.1039/b818665k. [DOI] [PubMed] [Google Scholar]
  • 34.Yu L, Wang J, Wu J, Tu S, Ding K. Angew Chem Int Ed. 2010;49:3627–3630. doi: 10.1002/anie.200906405. [DOI] [PubMed] [Google Scholar]
  • 35.Patureau FW, Siegler MA, Spek AL, Sandee AJ, Jugé S, Aziz S, Berkessel A, Reek JNH. Eur J Inorg Chem. 2012:496–503. [Google Scholar]
  • 36.Meeuwissen J, Sandee AJ, de Bruin B, Siegler MA, Spek AL, Reek JNH. Organometallics. 2010;29:2413–2421. [Google Scholar]
  • 37.Meeuwissen J, Detz R, Sandee AJ, de Bruin B, Siegler MA, Spek AL, Reek JNH. Eur J Inorg Chem. 2010:2992–2997. [Google Scholar]
  • 38.Meeuwisen J, Kuil M, van der Burg AM, Sandee AJ, Reek JNH. Chem Eur J. 2009;15:10272–10279. doi: 10.1002/chem.200901110. [DOI] [PubMed] [Google Scholar]
  • 39.Wieland J, Breit B. Nature Chem. 2010;2:832–837. doi: 10.1038/nchem.800. [DOI] [PubMed] [Google Scholar]
  • 40.De Greef M, Breit B. Angew Chem Int Ed. 2009;48:551–554. doi: 10.1002/anie.200805092. [DOI] [PubMed] [Google Scholar]
  • 41.Laungani AC, Breit B. Chem Commun. 2008:844–846. doi: 10.1039/b716529c. [DOI] [PubMed] [Google Scholar]
  • 42.Kokan Z, Kirin S. RSC Adv. 2012 doi: 10.1039/C2RA20598J. [DOI] [Google Scholar]
  • 43.Muramulla S, Zhao CG. Tetrahedron Lett. 2011;52:3905–3908. [Google Scholar]
  • 44.Li Y, Feng Y, He YM, Chen F, Pan J, Fan QH. Tetrahedron Lett. 2008;49:2878–2881. [Google Scholar]
  • 45.Pignataro L, Boghi M, Civera M, Carboni S, Piarulli U, Gennari C. Chem Eur J. 2012;18:1383–1400. doi: 10.1002/chem.201102018. [DOI] [PubMed] [Google Scholar]
  • 46.Pignataro L, Carboni S, Civera M, Colombo R, Piarulli U, Gennari C. Angew Chem Int Ed. 2010;49:6633–6637. doi: 10.1002/anie.201002958. [DOI] [PubMed] [Google Scholar]
  • 47.Ohmatsu K, Ito M, Kunienda T, Ooi T. Nature Chem. 2012;4:473–477. doi: 10.1038/nchem.1311. [DOI] [PubMed] [Google Scholar]
  • 48.Brown JM, Deeth RJ. Angew Chem Int Ed. 2009;48:4476–4479. doi: 10.1002/anie.200900697.; and references cited therein
  • 49.Knowles RR, Jacobsen EN. PNAS. 2010;107:20678–20685. doi: 10.1073/pnas.1006402107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Wieland J, Breit B. Nature Chem. 2010;2:832–837. doi: 10.1038/nchem.800. [DOI] [PubMed] [Google Scholar]
  • 51.Meeuwissen J, Reek JNH. Nature Chem. 2010;2:615–621. doi: 10.1038/nchem.744. [DOI] [PubMed] [Google Scholar]
  • 52.Takacs JM, Reddy DS, Moteki SA, Wu D, Palencia H. J Am Chem Soc. 2004;126:4494–4495. doi: 10.1021/ja049873+. [DOI] [PubMed] [Google Scholar]
  • 53.Moteki SA, Takacs JM. Angew Chem Int Ed. 2008;47:894–897. doi: 10.1002/anie.200703127. [DOI] [PubMed] [Google Scholar]
  • 54.Moteki SA, Toyama K, Liu Z, Ma J, Holmes A, Takacs JM. Chem Comm. 2012;48:263–265. doi: 10.1039/c1cc16146f. [DOI] [PubMed] [Google Scholar]
  • 55.Takacs JM, Hrvatin PM, Atkins JM, Reddy DS, Clark JL. New J Chem. 2005;29:263–265. [Google Scholar]
  • 56.Atkins JM, Reddy DS, Moteki SA, DiMagno SG, Takacs JM. Org Lett. 2006;8:2759–2762. doi: 10.1021/ol060836s. [DOI] [PubMed] [Google Scholar]
  • 57.In the present context, ST and RT in SAL (STRT) each represent one from among tethers A–P for the (S,S)-5 and (R,R)-5 box derivatives, respectively.
  • 58.Takacs JM, Chaiseeda K, Moteki SA, Reddy DS, Wu D, Chandra K. Pure Appl Chem. 2006;78:501–509. [Google Scholar]
  • 59.Drexler HJ, You J, Zhang S, Fischer C, Baumann W, Spannenberg A, Heller D. Org Process Res Dev. 2003;7:355–361. [Google Scholar]
  • 60.Alternative catalyst precursors, e. g., Rh(cod)2BF4, Rh(cod)2SbF6, Rh(cod)2OTf give similar results under these reactions conditions.
  • 61.Reetz MT, Sell T, Meiswinkel A, Mehler G. Angew Chem Int Ed. 2003;42:790–793. doi: 10.1002/anie.200390209. [DOI] [PubMed] [Google Scholar]
  • 62.Reetz MT, Fu Y, Meiswinkel A. Angew Chem Int Ed. 2006;45:1412–1415. doi: 10.1002/anie.200503604. [DOI] [PubMed] [Google Scholar]
  • 63.Reetz MT, Mehler G, Bondarev O. Chem Commun. 2006:2292–2294. doi: 10.1039/b601638c. [DOI] [PubMed] [Google Scholar]
  • 64.Note that tether subunits A, B, and H were largely omitted from the set of SALs screened in this study.
  • 65.Reetz MT. Angew Chem Int Ed. 2008;47:2556–2588. doi: 10.1002/anie.200704327. [DOI] [PubMed] [Google Scholar]
  • 66.As a side note, we find a similar trend in other reactions using these or other similar supramolecular catalysts.
  • 67.The yellow data points in Graph A are for catalysts that incorporate only tethers C–G, the blue only I–P, and the green are for mixed combinations of (C–G) and (I–P).
  • 68.After much initial controversy, a similar balance is now generally accepted in enzymatic catalysts. For example, see: Koshland DE. Nature. 2004;4323:447. doi: 10.1038/432447a.
  • 69.For example, the SALs and catalysts bearing aryloxy-linkages are the empirically determined preferred motif in the rhodium-catalyzed asymmetric hydroboration of substituted styrenes with pinacolborane; see ref 49.
  • 70.Zhang Q, Takacs JM. Org Lett. 2008;10:545–548. doi: 10.1021/ol702890s. [DOI] [PubMed] [Google Scholar]
  • 71.Burk MJ, Wang YM, Lee JR. J Am Chem Soc. 1996;118:5142–5143. [Google Scholar]
  • 72.Zhu G, Casalnuovo AL, Zhang X. J Org Chem. 1998;63:8100–8101. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001
2_si_002

RESOURCES